Yahoo Finance • 19 days ago
NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Cybin Inc. (“Cybin” or the “Company”) (NYSE: CYBN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.co... Full story
Yahoo Finance • 29 days ago
NEW YORK, Sept. 14, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Cybin Inc. (“Cybin” or the “Company”) (NYSE: CYBN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.... Full story
Yahoo Finance • last month
NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Cybin Inc. (“Cybin” or the “Company”) (NYSE: CYBN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.co... Full story
Yahoo Finance • last month
Markets reopened after the Labor Day break on softer footing, with futures tied to the major indexes pointing lower. Investors are balancing several pressures at once: gold prices have surged to fresh record highs above $3,550 an ounce, si... Full story
Yahoo Finance • 2 months ago
Investing.com - H.C. Wainwright has reiterated its Buy rating and $150 price target on Cybin Inc. (NYSE:CYBN) following the company’s fiscal first quarter 2026 results. According to InvestingPro data, analysts maintain a strong buy conse... Full story
Yahoo Finance • 2 months ago
* Cybin press release [https://seekingalpha.com/pr/20200373-cybin-reports-important-progress-on-key-milestones-and-first-quarter-fiscal-year-2026] (NYSE:CYBN [https://seekingalpha.com/symbol/CYBN]): Q1 cash totaled $118.7 million as of J... Full story
Yahoo Finance • 2 months ago
Austin, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Psychedelic Drugs Market Size & Growth Outlook According to SNS Insider, the global Psychedelic Drugs Market was valued at USD 3.63 billion in 2024 and is projected to reach USD 10.11 billion by... Full story
Yahoo Finance • 3 months ago
Investing.com - Canaccord Genuity lowered its price target on Cybin Inc. (NYSE:CYBN) to $70.00 from $73.00 on Tuesday, while maintaining a Buy rating following the company’s fiscal fourth-quarter 2025 results. Currently trading at $7.87,... Full story
Yahoo Finance • 3 months ago
PALM BEACH, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Worldwide, there is a rising demand for neuropsychiatric disorder treatments which is expected to fuel the global markets for years to come. With expand... Full story
Yahoo Finance • 3 months ago
* Cybin press release [https://seekingalpha.com/pr/20152717-cybin-reports-fiscal-year-2025-financial-results-and-recent-business-highlights] (NYSE:CYBN [https://seekingalpha.com/symbol/CYBN]): Q4 Cash totaled C$135 million as of March 31... Full story
Yahoo Finance • 5 months ago
Key Takeaways; Cannabis Sector MediPharm pushed back against Apollo’s boardroom challenge Organigram was named “Exporter of the Year” for cannabis innovation and global reach Green Thumb posted solid Q1 2025 results, as the company focuse... Full story
Yahoo Finance • 2 years ago
In this article, we discuss the 11 popular penny stocks on Robinhood. If you want to skip our detailed analysis of these stocks, go directly to 5 Popular Penny Stocks on Robinhood. Even though the United States economy has battled recessi... Full story
Yahoo Finance • 3 years ago
In this article, we discuss 10 best psychedelic stocks to buy according to hedge funds. If you want to see more stocks in this selection, check out 5 Best Psychedelic Stocks to Buy According to Hedge Funds. Data Bridge Market Research pre... Full story
Yahoo Finance • 3 years ago
In this article, we discuss 10 most promising psychedelic stocks according to analysts. If you want to see more stocks in this selection, check out 5 Most Promising Psychedelic Stocks According To Analysts. Psychedelic drugs encompass a r... Full story